ARCHIVES

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Patient Advocates; NBCC Delivers 2.6M Signatures, demands 2.6Billion

May 9, 1997

In Belief: Warren Ross Named Director Of Louisville’s Brown Cancer Center; NCI Landow Offices Moved

August 5, 1988

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007

Treatment Progress Stirs Up Big ASCO turnout; Reports Presented

May 14, 1976

NIH Director Collins Publishes Third Book About Faith In God

March 5, 2010

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

March 30, 2001